For severe asthma patients

For your Severe Asthma patients, let's give them another choice

Bronchial Thermoplasty (BT) is a minimally invasive outpatient procedure for adults with severe asthma.

Bronchial Thermoplasty (BT): outpatient procedure proven to last for at least 5 years for patients with Severe Asthma1

Severe exacerbations

Bronchial Thermoplasty Works To Reduce Severe Exacerbations

Asthma experts around the world recommend Bronchial Thermoplasty

Hear from Experts
Who is BT for?

Who is BT for?

Many patients' lives are interrupted by asthma exacerbations, despite being prescribed a maximum medication regimen. These patients may try to avoid exacerbations by modifying their daily activities—even those that they enjoy.

Patients experienced a significant improvement in asthma-related quality of life as a result of BT (79% responder rate).2

Asthma experts recommend considering BT before maintenance oral corticosteroids 3

Partner with a BT physician for your patients with Severe Asthma

With hundreds of BT physicians worldwide, chances are there's a BT-Certified pulmonologist near you.

Bronchial Thermoplasty is performed throughout the world by BT-Certified pulmonologists who undergo a rigorous training and qualification process.

Brief Statement of Relevant Indications for Use, Contraindications, Warnings, and Adverse Events: The Alair™ Bronchial ThermoplastySystem is indicated for the treatment of severe persistent asthma in patients 18 years and older whose asthma is not well controlled with inhaled corticosteroids and long-acting beta-agonists. The Alair System is not for use in patients with an active implantable electronic device or known sensitivity to medications used in bronchoscopy. Previously treated airways of the lung should not be retreated with the Alair System. Patients should be stable and suitable to undergo bronchoscopy. The most common side effect of BT is an expected transient increase in the frequency and worsening of respiratory-related symptoms. ENDO-551804-AA
As with any procedure, there are risks, and individual results may vary. The most common adverse event of BT is a temporary worsening of respiratory-related symptoms. These events typically occur within one day of the BT procedure and usually resolve within a week with standard care. There is a small risk (3.4% per procedure) that symptoms may require hospitalization.2


  1. Wechsler M et al. J Allergy Clin Immunol. 2013 Dec;132(6):1295-302.
  2. Castro M et al. Am J Respir Crit Care Med. 2010 Jan 15;181(2):116-24.
  3. Adapted from the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2014. Available from: